Radioimmunotherapy could cure fungal diseases
Micrograph image of a pulmonary Aspergillus hyphae infection. Such infections develop mainly in individuals who are immunocompromised© Nephron wikicommons
Invasive fungal infections (IFI) are a major threat to individuals with cancer, transplants, HIV, and other conditions that weaken their immune system. New research has shown that radioimmunotherapy (RIT) could be a promising avenue for development of new types of treatment of fungal diseases. The research is published in a paper co-authored by JRC scientists in the framework of collaboration with the Albert Einstein College of Medicine (AECM) in New York.
The results of the research project indicate that RIT could have distinct advantages over existing therapies: it can better remove fungal pathogens, is less likely to lead to development of resistant strains, and may shorten the duration of the treatment. In addition, RIT is less toxic than the current antifungals.